A new technique enables the analysis of human microglia from postmortem brain tissues, critical in studying the role of these cells in neurodegenerative diseases including ALS.
Read more »
The structure of TDP-43 aggregates may hold the key to the clinical subtype of FTD, including progression rates.
Read more »
Could a cancer medicine targeting PARPs potentially be repurposed as a therapy for ALS? A new study suggests its a possibility.
Read more »
An emerging test may help detect and monitor cognitive decline in people with neurodegenerative diseases.
Read more »
Researchers are increasingly turning to proteomics to discover the underlying etiology of FTD, and thereby, targets of the disease.
Read more »
Emerging methods aim to detect and track early FTD, key in testing potential therapies in clinical trials.
Read more »
Tracking cohorts of people with FTD provide the groundwork for testing FTD therapies by defining and characterizing subtypes of the disease.
Read more »
A block in intra-axonal protein synthesis may explain why some neurons are vulnerable to ALS.
Read more »
